Webinar: Cell Therapy Development With Non-Viral Gene Engineering

Recently, advances in non-viral gene engineering methods, including transposon-based systems, have provided developers with an alternative gene engineering method that addresses the limitations of virus-based gene delivery systems. Utilizing a “cut-and paste” method of gene delivery, transposon-based systems are capable of stable genomic integration. TcBuster™ is one such transposon-based system and in this webinar, we will present data demonstrating both T cell and NK cell gene editing using the technology.

After the webinar, continue learning about TcBuster and gene engineering by consulting with one of our experts or reading the Lentiviral vs. Non-viral Gene Transfer for CAR-T Manufacturing application note.